A new crop of cancer immunotherapy drugs is showing promise in a widening range of tumor types, while researchers home in on ways to predict which patients are likely to benefit most from the drugs.
from WSJ.com: US Business http://ift.tt/1Bv1jHK
via IFTTT
No comments:
Post a Comment